Tempus AI推出新型HRD-RNA癌症检测算法

Core Viewpoint - Tempus AI has launched a new HRD-RNA cancer detection algorithm that provides real-time assessment of tumor functional status by analyzing gene expression rather than structural DNA damage [1] Group 1: Technology and Methodology - The HRD-RNA approach allows for the detection of HRD in patients and cancer types where genomic scars are difficult to identify [1] - This method differs from traditional DNA testing, focusing on RNA analysis to evaluate cancer [1] Group 2: Clinical Implications - A real-world validation study indicates that HRD-RNA positive metastatic pancreatic cancer patients receiving first-line platinum-based therapy have a significantly lower risk of death compared to those receiving non-platinum first-line treatment [1] - Complete supporting data for this study is expected to be published later this year [1]